Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124618322 | 12461832 | 2 | F | 20160525 | 20160805 | 20160613 | 20160815 | EXP | PHHY2016IT080573 | NOVARTIS | 59.00 | YR | M | Y | 0.00000 | 20160815 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124618322 | 12461832 | 1 | PS | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | Oral | 150 MG, QD | 750 | MG | Y | 19201 | 150 | MG | QD | ||||
| 124618322 | 12461832 | 2 | C | SIRDALUD | TIZANIDINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124618322 | 12461832 | 1 | Neck pain |
| 124618322 | 12461832 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124618322 | 12461832 | OT |
| 124618322 | 12461832 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124618322 | 12461832 | Anaphylactic reaction | |
| 124618322 | 12461832 | Facial bones fracture | |
| 124618322 | 12461832 | Fall | |
| 124618322 | 12461832 | Syncope | |
| 124618322 | 12461832 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124618322 | 12461832 | 1 | 20160521 | 20160525 | 0 |